| Literature DB >> 36198717 |
Lan Huong Timm1,2, Gasser Farrag3, Daniel Wolf3, Martin Baxmann4, Falk Schwendicke5.
Abstract
Patient compliance is relevant to achieving therapeutic goals during clear aligner therapy (CAT). The aim of this study was to evaluate the efficacy of remote electronic (e-)reminders and e-feedback on compliance during CAT using an interrupted time series (ITS) analysis. We used routinely collected mobile application data from a German healthtech company (PlusDental, Berlin). Our primary outcome was self-reported compliance (aligner wear time min. 22 h on 75% of their aligners were classified as fully compliant, min. 22 h on 50-74.9% of their aligners: fairly compliant; min. 22 h on < 50% of their aligners: poorly compliant). E-reminders and e-feedback were introduced in the 1st quarter of 2020. Compliance was assessed at semi-monthly intervals from June-December 2019 (n = 1899) and June-December 2020 (n = 5486), resulting in a pre- and post-intervention group. ITS and segmented regression modelling were used to estimate the effect on the change in levels and trends of poor compliance. Pre-intervention, poor compliance was at 24.47% (95% CI: 22.59% to 26.46%). After the introduction of e-reminders and e-feedback (i.e., post-intervention), the percentage of poorly compliant patients decreased substantially, levelling off at 9.32% (95% CI: 8.31% to 10.45%). E-reminders and e-feedback were effective for increasing compliance in CAT patients.Clinical Significance: Orthodontists and dentists may consider digital monitoring and e-reminders to improve compliance and increase treatment success.Entities:
Mesh:
Year: 2022 PMID: 36198717 PMCID: PMC9534859 DOI: 10.1038/s41598-022-20820-5
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.996
Figure 1Flowchart of the included groups.
Cohort characteristics, stratified into pre-and post-intervention periods.
| Covariates | Pre-intervention | Post-intervention | |
|---|---|---|---|
| No. of subjects (n) | 1899 | 5486 | |
| Age (mean ± SD) | 28.8 ± 7.4 | 29.1 ± 8.1 | 0.13 |
| Gender, female / male (%) | 75.6% / 24.4% | 70.6% / 29.4% | < 0.001 |
Age 18- to 35- years old (%) Age 36- to 55- years old (%) Age 56- to 64- years old (%) | 1601 (84.3%) 286 (15.1%) 12 (0.6%) | 4456 (81.2%) 984 (17.9%) 46 (0.8%) | < 0.05 |
Compliance in the pre-and post-intervention cohorts, stratified by age group and by gender. A Chi-square test was used to test for differences in the strata in each cohort.
| Pre-Intervention | Post-Intervention | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Overall sample | Full compliance | Fair compliance | Poor compliance | Chi-square | Overall sample | Full compliance | Fair compliance | Poor compliance | Chi-square | |
| Male | 463 (24.4%) | 185 (9.7%) | 197 (10.4%) | 81 (4.3%) | X2 (2, n = 1899) = 16.72 ( | 1615 (29.4%) | 763 (13.9%) | 648 (11.8%) | 204 (3.7%) | X2 (2, n = 5486) = 19.39 ( |
| Female | 1436 (75.6%) | 518 (27.3%) | 532 (28.0%) | 386 (20.3%) | 3871 (70.6%) | 1619 (29.8%) | 1614 (29.7%) | 638 (11.7%) | ||
| 18- to 35- years old | 1601 (84.3%) | 588 (31.0%) | 616 (32.4%) | 397 (20.9%) | X2 (4, n = 1899) = 2.80 | 4456 (81.2%) | 1925 (35.1%) | 1843 (33.6%) | 688 (12.5%) | X2 (4, n = 5486) = 1.28 |
| 36- to 55- years old | 286 (15.1%) | 112 (5.9%) | 109 (5.7%) | 65 (3.4%) | 984 (17.9%) | 438 (8.0%) | 401 (7.3%) | 145 (2.6%) | ||
| 56- to 64- years old | 12 (0.6%) | 3 (0.2%) | 4 (0.1%) | 5 (0.3%) | 46 (0.8%) | 19 (0.3%) | 18 (0.3%) | 9 (0.2%) | ||
| Total | 1899 (100%) | 703 (37.0%) | 729 (38.4%) | 467 (24.6%) | 5486 (100%) | 2382 (43.4%) | 2262 (41.2%) | 842 (15.3%) | ||
Compliance within gender groups pre-and post-intervention. A Chi-square test was used to test for differences between intervention groups.
| Full Compliance | Fair Compliance | Poor Compliance | Chi-Square | |
|---|---|---|---|---|
| Pre-intervention | 518 (36.1%) | 532 (37.0%) | 386 (26.9%) | X2 (2, n = 5307) = 72.89 |
| Post-intervention | 1619 (41.8%) | 1614 (41.7%) | 638 (16.5%) | |
| Pre-intervention | 185 (40.0%) | 197 (42.5%) | 81 (17.5%) | X2 (2, n = 2078) = 10.91 |
| Post-intervention | 763 (47.2%) | 648 (40.1%) | 204 (12.6%) | |
Figure 2Mean poor compliance by starting date of treatment. Note that this figure contains data from the mid-period (January to June 2020), which was excluded from the statistical analysis.
Figure 3Mean poor compliance by starting date of treatment, split by gender. The dashed vertical line indicates the gap between the two segments.
Figure 4Mean poor compliance by starting date of treatment, split by age range. The dashed vertical line indicates the gap between the two segments. The age range 56–64 was excluded from the figure due to the low number of patients in this age group.
The coefficients of the MMI model.
| Coefficient | 95% confidence interval | Akaike weight | |
|---|---|---|---|
| Constant term (β0) | − 1.03 | (− 1.14, − 0.92) | 1.00 |
| Segment A (β2) | 0.31 | (0.11, 0.50) | 1.00 |
| Segment A time (β3) | − 0.35 | (− 0.46, − 0.24) | 1.00 |
| Segment B (β4) | − 1.13 | (− 1.29, − 0.97) | 1.00 |
| Gender_m (β6) | − 0.40 | (− 0.55, − 0.26) | 1.00 |
| Age_56_64 (β8) | 0.42 | (− 0.19, 1.04) | 0.46 |
Figure 5The MMI model by starting date of treatment. The purple line gives the point estimates of expected poor compliance while the purple shaded area is the 95% confidence band. Each point indicates the mean poor compliance of the given group, whereby the size of the point is proportional to the number of patients contained within that group. Points with fewer than 5 patients were excluded from the figure. The dashed vertical line indicates the gap between the two segments.